Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant cisplatin + gemcitabine vs upfront surgery in resectable proximal biliary tract cancer
2014-002382-30Phase 2Unknown
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin and gemcitabine in biliary cancer and gallbladder cancer (2 arms), sponsored by The Clatterbridge Cancer Centre NHS Foundation Trust. Primary endpoint: Overall survival. Status: unknown.
02
Drugs
cisplatingemcitabine
03
Conditions
biliary cancergallbladder cancer
Beyond the preview
Go deeper on 2014-002382-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002382-30.